Clinical Trials Browser

Recruiting × Adenoma, Islet Cell × 90 days × Clear all

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT06943755 2026-04-17

STELLAR-311

Phase 2/3 Recruiting

440 enrolled

EndocrineNET

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT04924075 2026-04-13

MK-6482-015

Phase 2 Recruiting

322 enrolled 3 FDA

CNSEndocrine

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT05687123 2026-04-13

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Phase 1 Recruiting

24 enrolled

Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT07165132 2026-04-13

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Phase 1 Recruiting

104 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06141369 2026-04-09

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Phase NA Recruiting

21 enrolled

Endocrine

Adenoma, Islet Cell, Adrenocortical Carcinoma, Carcinoma, Medullary

NCT05477576 2026-03-30

ACTION-1

Phase 3 Recruiting

338 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT05847855 2026-03-25

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Recruiting

1,000 enrolled

Adenoma, Islet Cell

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Phase 1 Recruiting

18 enrolled

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT06202066 2026-03-11

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Phase 2 Recruiting

60 enrolled

Adenoma, Islet Cell

NCT00830557 2026-03-09

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Recruiting

20,000 enrolled

Gastrointestinal

Hereditary pancreatitis, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Pancreatitis, Somatostatinoma, Carcinoma, Islet Cell, Pancreatitis, Chronic

NCT05988918 2026-03-06

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Phase 2 Recruiting

66 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Somatostatinoma, Carcinoma, Adenosquamous

NCT07439757 2026-02-27

AI-Powered Precision Decision-Making for Pancreatic Diseases

Recruiting

2,000 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Adenoma, Islet Cell, Pancreatic Neoplasms, Pancreatitis, Pancreatitis, Chronic

NCT05746182 2026-01-26

PanNEN

Recruiting

300 enrolled

Adenoma, Islet Cell

NCT07273409 2026-01-22

PANTODON

Phase NA Recruiting

200 enrolled

Adenoma, Islet Cell

NCT07328607 2026-01-21

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

Phase NA Recruiting

90 enrolled

Adenoma, Islet Cell

Clinical Trials

Tumor HI

STELLAR-311

MK-6482-015

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

ACTION-1

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

AI-Powered Precision Decision-Making for Pancreatic Diseases

PanNEN

PANTODON

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy